Managing Disseminated Intravascular Coagulopathy

Pap Talk S4E15: MIRA surgical system for hysterectomy with Jean Dubuisson, MD, PhD

Experts urge the FDA to update outdated warnings on menopausal hormone therapies, emphasizing the safety and benefits of low-dose vaginal estrogen.

December 31st 2024

Distressed birth linked to long-term physical and mental health risks

In this episode of Pap Talk, Jean Dubuisson, MD, PhD, discusses the first successful hysterectomy performed using the MIRA surgical system.

Listen

How Individually Identifying More HPV Types Enables Better Patient Management and More Precise Care

Infants born preterm or with complications face higher risks of chronic conditions in adulthood, highlighting policy and health care needs.

September 29th 2023

DM199 shows promise in phase 2 trial for treating preeclampsia

Listen

Tirzepatide plus hormone therapy boosts weight loss in menopausal women

DiaMedica Therapeutics' investigational therapy DM199 significantly reduced blood pressure and improved uterine blood flow in patients with preeclampsia, with a favorable safety profile.

Experts urge FDA to revise boxed warnings on hormone therapies for menopause

Tirzepatide and menopause hormone therapy may significantly enhance weight loss and health outcomes in postmenopausal women.

Related Content

Morgan Ebert, Managing Editor

Pap Talk S4E15: MIRA surgical system for hysterectomy with Jean Dubuisson, MD, PhD

Experts urge the FDA to update outdated warnings on menopausal hormone therapies, emphasizing the safety and benefits of low-dose vaginal estrogen.

December 31st 2024

Distressed birth linked to long-term physical and mental health risks

In this episode of Pap Talk, Jean Dubuisson, MD, PhD, discusses the first successful hysterectomy performed using the MIRA surgical system.

Listen

How Individually Identifying More HPV Types Enables Better Patient Management and More Precise Care

Infants born preterm or with complications face higher risks of chronic conditions in adulthood, highlighting policy and health care needs.

September 29th 2023

DM199 shows promise in phase 2 trial for treating preeclampsia

Listen

Tirzepatide plus hormone therapy boosts weight loss in menopausal women

DiaMedica Therapeutics' investigational therapy DM199 significantly reduced blood pressure and improved uterine blood flow in patients with preeclampsia, with a favorable safety profile.